Efficacy and Safety of QL1012 in Women for Assisted Reproductive Treatment

Inclusion Criteria: 1. Signed informed consent 2. Aged 20 \~ 39 years(inclusive) 3. Body mass index (BMI) between 18\~30 kg/m2(inclusive) 4. Regular menstrual cycle (25\~35 days) 5. Basal FSH \< 10 IU/L (menstrual cycle day 2\~5) Exclusion Criteria: 1. History of ≥3 previously completed IVF/ICSI-ET cycles without clinical pregnancy 2. History of ≥3 recurrent spontaneous miscarriages 3. Patients with high risk of ovarian hyperstimulation syndrome (OHSS) 4. Primary ovarian failure or poor responders to ovarian stimulation 5. Presence of pregnancy in previous 3 months 6. Presence of clinically significant systemic disease, endocrine disease or metabolic abnormalities 7. History of malignant tumors of the ovary, breast, uterus, hypothalamus, pituitary gland, etc.;